Indirect evidence exists implicating vascular nitric oxide in the path
ogenesis of arterial vasodilation in cirrhosis. In the current study,
a coincubation assay to estimate the vascular nitric oxide production
was developed and the nitric oxide production by arterial segments of
cirrhotic and control rats was assessed. In the assay, measurement of
reporter monolayer cell-associated cGMP levels allows the influence of
nitric oxide released by arterial segments to be determined. RFL-6 ce
lls served as reporter cells. Nitric oxide production was determined i
n thoracic aorta and mesenteric arteries of 22 control rats, 10 cirrho
tic rats without ascites, and 12 cirrhotic rats with ascites. Basal an
d bradykinin-stimulated (10(-6) mol/L) intracellular content of nitric
oxide-dependent cGMP was significantly higher in RFL-6 cells coincuba
ted with aortic segments of cirrhotic rats with (21.3 +/- 3.6 pmol/10(
5) cells, P < .05 and 44.7 +/- 7.0 pmol/10(5) cells, P < .025) and wit
hout ascites (15.3 +/- 3.0 pmol/10(5) cells, P < .05 and 43.2 +/- 7.6
pmol/10(5) cells, P < .05) than in those incubated with aortic segment
s of control rats (9.7 +/- 1.3 and 19.5 +/- 2.5 pmol/10(5) cells). RFL
-6 cells exposed to bradykinin-stimulated mesenteric arterial segments
of cirrhotic rats also showed increased cGMP content (ascitic: 2.73 /- 0.31 pmol/10(5) cells, P < .005; nonascitic: 2.58 +/- 0.51 pmol/10(
5) cells, P < .025) compared with cells exposed to control mesenteric
arterial segments (1.28 +/- 0.15 pmol/10(5) cells). No differences bet
ween cirrhotic and control vessels were observed after endothelium den
udation. These results indicate that basal and bradykinin-stimulated v
ascular nitric oxide production is higher in cirrhotic rats with and w
ithout ascites than in control rats in and that the endothelial lining
is the site where vascular L-arginine nitric oxide pathway activation
takes place in experimental cirrhosis.